Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.

Buckley, M J; Xia, H X; Hyde, D M; Keane, C T; O'Morain, C A

Buckley, M J; Xia, H X; Hyde, D M; Keane, C T; O'Morain, C A.

Affiliation

Buckley MJ; Department of Gastroenterology, Meath/Adelaide Hospitals, Dublin, Ireland.

Dig Dis Sci ; 42(10): 2111-5, 1997 Oct.

Article in En | MEDLINE | ID: mdl-9365144

Subject(s)

Anti-Bacterial Agents/antagonists & inhibitors; Anti-Ulcer Agents/antagonists & inhibitors; Clarithromycin/antagonists & inhibitors; Drug Resistance, Multiple; Metronidazole/antagonists & inhibitors; Adult; Aged; Anti-Bacterial Agents/administration & dosage; Anti-Ulcer Agents/administration & dosage; Clarithromycin/administration & dosage; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer/drug therapy; Duodenal Ulcer/microbiology; Dyspepsia/drug therapy; Dyspepsia/microbiology; Helicobacter Infections/drug therapy; Helicobacter Infections/microbiology; Helicobacter pylori/drug effects; Helicobacter pylori/isolation & purification; Humans; Metronidazole/administration & dosage; Microbial Sensitivity Tests; Middle Aged; Omeprazole/administration & dosage; Time Factors; Treatment Failure

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Clarithromycin / Drug Resistance, Multiple / Metronidazole / Anti-Ulcer Agents / Anti-Bacterial Agents Type of study: Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Dig Dis Sci Year: 1997 Document type: Article Affiliation country: Ireland Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links